Qianjiang Yongan Pharmaceutical Co., Ltd. was established in 2001. It is located in the National High-tech Industrial Development Zone of Qianjiang City, the hinterland of the Jianghan Plain. It covers an area of ​​more than 500 mu. It is a national high-tech enterprise with independent intellectual property rights. The company's shares were listed on the Shenzhen Stock Exchange on March 5, 2010 (stock code 002365). The company has strong technical development capabilities and is an innovative enterprise in Hubei Province and a demonstration enterprise in intellectual property construction in Hubei Province. The company's R&D platforms are respectively recognized as provincial enterprise technology centers and Hubei Province Functional Food Additive Engineering Technology Research Center. After years of development, the company has formed an overall pattern of production and sales of food and pharmaceutical additives taurine as the main body, and production and sales of ethylene oxide and water reducing agents and health products extending upstream and downstream.

The company's own production process of taurine "ethylene oxide" was established by the company and has obtained the "Torch Program" certificate issued by the Ministry of Science and Technology.

The company has a complete quality control system, has passed the certification of GMP, ISO9001, ISO22000, BRC and FAMI-QS, and has obtained the KOSHER certificate issued by the United States OU and the HALAL certificate issued by the International Islamic Organization. 80% of the company's taurine products are exported around the world, and are an important supplier to companies such as Red Bull, Nestle, and Coca-Cola.

In 2017, the newly built food additive project of 30,000 tons of taurine annual output is highly consistent with the development strategy of "Made in China 2025", deeply integrated new technological achievements, and achieved the full link of taurine synthesis, crystallization purification, packaging, storage and transportation. Split automation and overall intelligence have achieved early self-perception of information, intelligent optimization and self-decision, precise control and self-execution, improving production efficiency and improving product quality. At present, the company's taurine production capacity has reached 58,000 tons per year, and production and manufacturing have been fully upgraded.

The company has an annual production device of 40,000 tons of ethylene oxide, adopts the alcohol process of the American SD company, and is supplemented by the ethylene method to effectively avoid the risk of price fluctuations of a single raw material.

In the first half of 2019, Hubei Ling'an Technology Co., Ltd., a holding subsidiary of the company, completed the construction of the "112,000 tons/year low-carbon epoxy derivative fine chemical new materials" project and successfully put into production, forming a good result with the production of ethylene oxide. Synergistic effect.

Yong'an Kangjian Pharmaceutical (Wuhan) Co., Ltd. has established a complete "YATEK®" product research and development system, intervening in product research and development from multiple key technical links such as functional factor screening, formulating, conveying, and evaluation, and adopting a variety of advanced Patented modular preparation technology maximizes the efficiency of functional dietary nutritional products development. By continuously deepening business cooperation with Canadian health brand, Bodybuilding Student, actively grafting international resources, achieving complementary advantages, and gradually forming a large pattern of integrated development of "Chinese capital + overseas brands".

The company will continue to be committed to technological improvement and innovation, and with the help of the capital market engine power, it will further improve the company's industrial chain, and with the mission of "working for human health", it will strive to build the company into a world-class human health promoter.